Lebenthal Global Advisors LLC Has $2.20 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Lebenthal Global Advisors LLC boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 6.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,693 shares of the biotechnology company’s stock after buying an additional 215 shares during the quarter. Lebenthal Global Advisors LLC’s holdings in Axon Enterprise were worth $2,195,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Foundations Investment Advisors LLC boosted its holdings in shares of Axon Enterprise by 10.1% during the 4th quarter. Foundations Investment Advisors LLC now owns 608 shares of the biotechnology company’s stock worth $361,000 after buying an additional 56 shares in the last quarter. Pacer Advisors Inc. boosted its holdings in Axon Enterprise by 85.8% in the fourth quarter. Pacer Advisors Inc. now owns 9,763 shares of the biotechnology company’s stock worth $5,802,000 after acquiring an additional 4,509 shares in the last quarter. Blue Trust Inc. grew its stake in Axon Enterprise by 70.4% in the fourth quarter. Blue Trust Inc. now owns 496 shares of the biotechnology company’s stock valued at $295,000 after acquiring an additional 205 shares during the period. Kingswood Wealth Advisors LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $525,000. Finally, Jacksonville Wealth Management LLC bought a new position in shares of Axon Enterprise in the 4th quarter worth $2,904,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 2.9 %

Shares of AXON stock opened at $592.54 on Monday. Axon Enterprise, Inc. has a 12-month low of $247.04 and a 12-month high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a 50 day moving average of $617.65 and a 200-day moving average of $472.00. The firm has a market cap of $45.18 billion, a P/E ratio of 153.11, a PEG ratio of 6.09 and a beta of 1.04.

Analyst Ratings Changes

Several equities research analysts have recently commented on AXON shares. TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. Needham & Company LLC boosted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, The Goldman Sachs Group raised their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $504.92.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the transaction, the insider now owns 124,243 shares of the company’s stock, valued at $77,586,026.21. The trade was a 0.83 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,545 shares of company stock worth $30,721,337. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.